Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.

Fothergill JL, Mowat E, Ledson MJ, Walshaw MJ, Winstanley C.

J Med Microbiol. 2010 Apr;59(Pt 4):472-81. doi: 10.1099/jmm.0.015875-0. Epub 2009 Dec 17.

PMID:
20019149
2.

Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.

Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C.

BMC Microbiol. 2007 May 23;7:45.

3.

Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.

Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1674-9. doi: 10.1164/rccm.201009-1430OC. Epub 2011 Feb 4.

PMID:
21297072
4.
5.
6.

Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.

Bradbury R, Champion A, Reid DW.

Respirology. 2008 Nov;13(6):886-92. doi: 10.1111/j.1440-1843.2008.01383.x.

PMID:
18811887
8.

A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.

Salunkhe P, Smart CH, Morgan JA, Panagea S, Walshaw MJ, Hart CA, Geffers R, Tümmler B, Winstanley C.

J Bacteriol. 2005 Jul;187(14):4908-20.

10.

Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland.

Logan C, Habington A, Lennon G, Grogan J, Byrne M, O'Leary J, O'Sullivan N.

J Med Microbiol. 2012 Jan;61(Pt 1):64-70. doi: 10.1099/jmm.0.035642-0. Epub 2011 Sep 15.

PMID:
21921114
11.

Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.

Dales L, Ferris W, Vandemheen K, Aaron SD.

Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1275-9. doi: 10.1007/s10096-009-0774-9. Epub 2009 Jul 3.

PMID:
19575248
12.

Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?

Wolter JM, Bowler SD, McCormack JG.

Aust N Z J Med. 1999 Feb;29(1):15-21.

PMID:
10200808
13.
14.

Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.

Finnan S, Morrissey JP, O'Gara F, Boyd EF.

J Clin Microbiol. 2004 Dec;42(12):5783-92.

15.

Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.

Etherington C, Hall M, Conway S, Peckham D, Denton M.

J Antimicrob Chemother. 2008 Feb;61(2):425-7. Epub 2007 Dec 21.

PMID:
18156280
16.
17.

PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas Aeruginosa.

Panagea S, Winstanley C, Parsons YN, Walshaw MJ, Ledson MJ, Hart CA.

Mol Diagn. 2003;7(3-4):195-200.

PMID:
15068391
18.

Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.

Mereghetti L, Marquet-van der Mee N, Loulergue J, Rolland JC, Audurier A.

Pathol Biol (Paris). 1998 May;46(5):319-24.

PMID:
9769892
19.

Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.

Tümmler B, Bosshammer J, Breitenstein S, Brockhausen I, Gudowius P, Herrmann C, Herrmann S, Heuer T, Kubesch P, Mekus F, Römling U, Schmidt KD, Spangenberg C, Walter S.

Behring Inst Mitt. 1997 Feb;(98):249-55. Review.

PMID:
9382747
20.

Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.

Leone I, Chirillo MG, Raso T, Zucca M, Savoia D.

Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1093-9. doi: 10.1007/s10096-008-0551-1. Epub 2008 May 17.

PMID:
18488256

Supplemental Content

Support Center